Logo

codevelopment agreement

Beckman Coulter Life Sciences, Pillar Biosciences Partner to Develop NGS Solutions

Under the agreement, Pillar Biosciences will develop applications designed for Beckman Coulter's Biomek NGenius System.

AmoyDx, Beckman Coulter to Develop Applications for NGS Library Prep Instrument

The Chinese diagnostic company will develop applications specifically designed for Beckman Coulter's forthcoming automated NGS library prep liquid handler.

In New Deal, Oncocyte Gains Global Market Runway, Thermo Fisher Nabs Steward for Clinical Kits
Premium

Company leaders discussed details about the practical and financial benefits the deal provides both firms this week.

SomaLogic's Illumina Codevelopment Deal Suggests Future of Label-Based Proteomics Lies in NGS
Premium

The assay development deal was "necessary to remain competitive" for SomaLogic, according to MD Anderson proteomics researcher Philip Lorenzi.

Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs

The companies are working together to bring to market in vitro diagnostic versions of Thermo Fisher's Oncomine Comprehensive Assay Plus and Oncocyte's DetermaIO test.

Jan 5, 2022

Illumina, SomaLogic Ink Codevelopment Agreement for Proteomics Assays With Sequencing Readout

Sep 10, 2021

Sophia Genetics Touts Informatics Deals With Weill Cornell, Agilent, Dasa
Premium

Sep 1, 2021

Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs

Aug 31, 2021

GenomSys, Philips to Build Genome Analysis Technology Based on MPEG-G Standard

Jul 6, 2021

Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare

Apr 22, 2021

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic

Apr 15, 2021

Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing
Premium

Feb 24, 2021

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Feb 9, 2021

UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing
Premium

Nov 18, 2020

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Aug 6, 2020

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

Jul 17, 2020

Saga Diagnostics, SensID to Codevelop Control Reagents for Cancer Mutation Detection

Jul 1, 2020

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test
Premium

May 5, 2020

CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test

Mar 17, 2020

Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease

Jan 15, 2020

PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay

Jan 13, 2020

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Dec 3, 2019

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Nov 7, 2019

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Nov 6, 2019

Mission Bio, BioLegend Partner on Single-Cell DNA-Protein Detection

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.